Histotype
Colon
| Parameter | Information |
|---|---|
| Strain | C57BL/6 |
| Implant Type | Cells |
| Implant Location | SC - Axilla (High) |
| Time to Staging | 12 days |
| Time to 750mm3 | 21.2 days |
| Td | 4 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Mouse
Ref #
9190
MC38: Murine Colon Adenocarcinoma
Learn more about this cell line in our scientific spotlights:
Colorectal cancer is the fourth most common cancer diagnosed in the United States. Colorectal cancer represents the third leading cause of cancer-related deaths in women and the second in men. In 2019, over 145,000 estimated new cases of colorectal cancer in the United States will be diagnosed and more than 51,000 patient deaths will occur. Prevention and early detection initiatives over the last several decades, together with improved treatment options, have resulted in reductions in colorectal cancer diagnoses and deaths. These measures have also increased the five-year overall survival rate to 64.9%, but survival drops precipitously for those patients whose cancer is not detected early.[1] For this reason, the development of new treatments for colorectal cancer is a continual need.